Clal Biotechnology Industries

About

Portfolio · 1

Pi-Cardia

A medical device company developing non-implant, catheter-based solutions for treating heart valve calcification and aortic stenosis.

1 round $10.0M committed Latest: 2016-01

Q&A

What is Clal Biotechnology Industries' primary investment focus?

Clal Biotechnology Industries (CBI) is a leading Israeli life sciences investment firm specializing in biotechnology, pharmaceuticals, diagnostics, and medical devices. They focus on innovative ventures addressing unmet medical needs.

When was Clal Biotechnology Industries established?

Clal Biotechnology Industries was established in 1993.

What is the typical check size for Clal Biotechnology Industries?

Clal Biotechnology Industries typically invests between $500,000 and $10,000,000 per company.

What are the preferred geographies for Clal Biotechnology Industries' investments?

Clal Biotechnology Industries prefers to invest in companies located in Israel and the United States.

What is the total AUM for Clal Biotechnology Industries?

Clal Biotechnology Industries has a total AUM of $600,000,000.

Who is the CEO of Clal Biotechnology Industries?

Ofer Gonen serves as the CEO of Clal Biotechnology Industries.

What investment stages does Clal Biotechnology Industries cover?

Clal Biotechnology Industries invests across various stages, including Pre-clinical, Incubation, Seed, Start-up, Early stage, Mid venture, Late venture, Emerging growth, Growth capital, PIPE, Series A, Series B, Series C, and Pre-IPO.

What is Clal Biotechnology Industries' investment thesis?

Clal Biotechnology Industries identifies and supports promising innovative ventures that develop proprietary solutions for unmet medical needs with multibillion-dollar market potential. They provide significant investments with hands-on leadership and guidance.